Home › Blog › Weight Loss › Weight Loss Injections Manchester
Weight Loss Injections Manchester 2026: All 10 Greater Manchester Districts, NHS Routes, and Private From £139
Get Weight Loss Injections in Manchester — Delivered Tomorrow, No Waiting List
Same MHRA-licensed Mounjaro and Wegovy as NHS Greater Manchester ICB · GPhC No. 1033729 · NHS-contracted · SCOPE Obesity Accredited · LegitScript Certified · Free monthly check-ins
Wegovy from £99.99/month
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ Next-day to all GM postcodes
Greater Manchester is England’s largest combined city-region by population outside London, with approximately 2.8 million people across 10 metropolitan districts. NHS Greater Manchester ICB — one of England’s pioneering devolved health authorities since 2016 — covers all 10 districts: Manchester City, Salford, Trafford, Stockport, Tameside, Oldham, Rochdale, Bury, Bolton, and Wigan. It is one of the most clinically complex ICBs in England for weight loss injection prescribing, combining some of England’s most deprived urban communities with more affluent suburban areas.
Greater Manchester’s obesity landscape is characterised by extreme variation. Trafford and Stockport have obesity rates around the national average. Oldham and Wigan have obesity rates exceeding 35–38%, with Oldham also home to one of England’s largest South Asian communities where ethnic BMI adjustments are clinically critical. NHS tier 3 weight management waiting times across the 10 districts range from 12 months in Trafford and Stockport to 24 months in Oldham and Wigan. Slinic is based in Brierfield, Lancashire — meaning Greater Manchester patients receive some of the fastest next-day deliveries of any area Slinic serves.
How to Get Weight Loss Injections in Manchester: NHS vs Private
| Factor | NHS — Greater Manchester ICB | Private — Slinic |
|---|---|---|
| Eligibility threshold | BMI 35+ with qualifying conditions (tier 3) · BMI 27+ with CVD no T2D (April 2026 Wegovy) · T2D patients (QOF Mounjaro) | BMI 30+ (no condition) · BMI 27+ with 1 qualifying condition · Ethnic group adjustments apply |
| GP referral needed | Yes — tier 3 referral or April 2026 GP direct pathways | No — free online assessment with Slinic |
| Waiting time | 12–24 months depending on your GM district | 24–48 hours from assessment to delivery |
| Cost in England | £9.90 per item · Free with T2D exemption, age 60+, or qualifying benefits | £139–£285/month (Mounjaro) · £99.99–£209.99 (Wegovy) · £4.99 delivery |
| Clinical monitoring | NHS GM ICB tier 3 multidisciplinary team | Free monthly check-ins with Slinic superintendent pharmacist — always included |
| Free starter pack | Via NHS tier 3 service | ✓ Needles + sharps bin with first order |
| Can run simultaneously? | ✓ Yes — both routes fully compatible. Starting private Slinic treatment does not affect your NHS GM ICB waiting list position. | |
All 10 Greater Manchester Districts — NHS Waiting Times and Area Profiles
NHS Greater Manchester ICB is unique in England in operating through a devolved health and care system since 2016. While eligibility criteria follow national NICE guidance, service delivery varies by locality across the 10 districts. Understanding your specific district matters significantly for both NHS waiting times and clinical context.
| GM district | Approx. tier 3 wait | Adult obesity rate | Key clinical characteristics | Main postcodes |
|---|---|---|---|---|
| Manchester City | 15–18 months | 29–36% (highest in Moss Side, Hulme, Gorton) | Extremely diverse. Large South Asian (Longsight, Rusholme, Levenshulme), Black African/Caribbean, and Somali communities. Very high T2D in South Asian areas. Ethnic BMI adjustments apply widely. Student population in city centre/Fallowfield affects averages. | M1–M23, M40, M60 |
| Salford | 15–18 months | 31–36% | Above-average deprivation. Mixed demographics. Above-average CVD and T2D. April 2026 CVD and T2D pathways both relevant. | M3, M5, M6, M7, M27–M30, M50 |
| Trafford | 12–15 months | 24–28% | More affluent. Below-average obesity overall. Shorter NHS waits than most GM districts. Higher proportion of patients choosing Slinic for speed and clinical credentials. | M14–M16, M31–M33, WA14–WA15 |
| Stockport | 12–15 months | 24–28% | More affluent. Below-average obesity overall. Shortest NHS waits in Greater Manchester. SK postcodes. | SK1–SK12 |
| Tameside | 15–20 months | 31–35% | Above-average deprivation. High obesity. Former industrial health legacy. Above-average CVD. OL6–OL7 and SK15–SK16 postcodes. | OL5–OL7, SK14–SK16 |
| Oldham | 18–24 months | 33–38% | Large South Asian community (Pakistani and Bangladeshi) — one of the highest proportions outside London. Very high T2D prevalence. Ethnic BMI adjustments widely applicable. QOF T2D pathway most clinically impactful GM district outside Manchester City. | OL1–OL4, OL8–OL9 |
| Rochdale | 18–22 months | 32–36% | Large South Asian community. Above-average T2D and CVD. OL10–OL16 postcodes. Ethnic BMI adjustments relevant for a significant proportion. | OL10–OL16 |
| Bury | 15–20 months | 28–32% | Mixed demographics. Above-average obesity. BL9 and BL8 postcodes cover Bury and Radcliffe. | BL8–BL9 |
| Bolton | 16–20 months | 30–34% | Above-average deprivation in parts. High obesity and CVD. South Asian community in Great Lever and Halliwell — ethnic adjustments relevant. BL1–BL7. | BL1–BL7 |
| Wigan | 18–24 months | 34–38% | High obesity. Deprived post-industrial communities. High CVD burden — April 2026 Wegovy CVD pathway particularly relevant. WN postcodes. | WN1–WN8 |
Oldham, Rochdale, and Bolton — Ethnic BMI Adjustments in Greater Manchester
Oldham has one of the highest proportions of South Asian residents — predominantly Pakistani and Bangladeshi — of any local authority outside London. Rochdale and parts of Bolton similarly have large and well-established South Asian communities. For patients from these communities across Greater Manchester, the ethnic BMI adjustment thresholds at Slinic are clinically important and frequently represent the difference between qualifying and not qualifying for treatment.
The clinical evidence is consistent across published literature: Diabetes UK documents that South Asian patients develop type 2 diabetes at significantly lower BMIs than white European patients. A Pakistani-heritage patient in Oldham with BMI 25 and hypertension faces equivalent metabolic risk to a white European patient with BMI 29 — but would only qualify at Slinic under adjusted criteria, not standard thresholds.
| Ethnic background | Standard Slinic threshold | Adjusted Slinic threshold | Greater Manchester areas most affected |
|---|---|---|---|
| South Asian (Pakistani, Bangladeshi, Indian, Sri Lankan) | BMI 30+ (no condition) · BMI 27+ (with condition) | BMI 27.5+ (no condition) · BMI 23+ (with condition) | Oldham (OL1–OL4, OL8–OL9), Rochdale (OL10–OL16), Bolton (BL1–BL3), Longsight/Rusholme/Levenshulme (M12–M14, M19), Trafford/Sale (M33) |
| Black African / Black Caribbean / Somali | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Moss Side, Hulme, Whalley Range in Manchester City (M14–M16), parts of Salford |
| Chinese / East Asian | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Manchester City Centre (M1–M4), parts of Trafford (M41) |
NHS Weight Loss Injections in Manchester: The Three Routes in 2026
NHS Greater Manchester ICB Tier 3 Weight Management
⏰ Wait: 12–15 months (Trafford, Stockport) · 15–20 months (Manchester, Salford, Tameside, Bury, Bolton) · 18–24 months (Oldham, Rochdale, Wigan)
The primary NHS route. GP refers you to NHS Greater Manchester ICB’s tier 3 specialist weight management service. Eligibility under NICE TA1026: BMI 35+ with at least one qualifying condition. NHS prescription charge: £9.90/item (free with T2D exemption, age 60+, or qualifying benefits).
- BMI 35+ with at least one qualifying condition
- GP referral required — ask your Manchester GP TODAY
- 12–24 months depending on your GM district
- Tier 3 services delivered through Manchester University NHS Foundation Trust and commissioned providers including Oviva
GP Cardiovascular Pathway — Wegovy for CVD Patients
⚡ Potentially weeks — particularly important for Wigan, Bolton, and Salford patients
Following NICE April 2026 cardiovascular guidance based on the SELECT trial (20% MACE reduction, NEJM 2023), Manchester GPs can now prescribe Wegovy directly for patients with BMI 27+, established CVD (prior MI, stroke/TIA, or peripheral arterial disease), and no T2D. Particularly relevant for Wigan, Bolton, and Tameside where CVD burden is above average.
If you have had a heart attack, stroke, or TIA in any GM district: ask your GP about the NICE April 2026 cardiovascular semaglutide prescribing pathway today.
QOF Type 2 Diabetes Pathway — Mounjaro for T2D Patients
⚡ Potentially weeks — particularly impactful for Oldham, Rochdale, and Bolton patients
From April 2026, Mounjaro is in the NHS GP QOF for type 2 diabetes. Manchester GP practices participating can prescribe Mounjaro for T2D patients without tier 3 referral. This pathway is critically important for Oldham and Rochdale patients who face 18–24 month tier 3 waits and have among the highest South Asian T2D prevalence rates outside London.
- Type 2 diabetes — the qualifying criterion
- GP practice must have adopted the QOF T2D pathway
- Mounjaro: dual licence for weight management AND T2D control simultaneously
If you have T2D in Oldham, Rochdale, Bolton, or any GM district: ask your GP — “Has your practice adopted the QOF tirzepatide T2D prescribing pathway?”
Step 1 (Today): Ask your Greater Manchester GP for an NHS tier 3 referral. Also ask about the April 2026 cardiovascular Wegovy pathway and QOF T2D Mounjaro pathway. Start the NHS clock now — your waiting time began the day you asked.
Step 2 (Today): Complete Slinic’s free 2-minute eligibility assessment simultaneously. If eligible, medication at your Manchester address tomorrow. Slinic is in Lancashire — deliveries to GM are among our fastest.
Step 3: Receive private Slinic treatment for 12–24 months while waiting. Free monthly check-ins throughout.
Step 4: When NHS GM ICB appointment arrives, transition to NHS supply at your current dose. £9.90/item in England (free with exemption). No restart from the lowest dose.
Starting private treatment does not affect your NHS Greater Manchester ICB waiting list position.
No 12–24 Month Wait at Slinic — Next-Day to All GM Postcodes
Mounjaro from £139 · Wegovy from £99.99 · Free monthly check-ins · GPhC No. 1033729 · NHS-contracted · Lancashire-based: fastest delivery to GM
Mounjaro for Manchester T2D Patients — Oldham, Rochdale, and Longsight
Oldham has T2D prevalence significantly above the national average, driven primarily by its large South Asian community. Rochdale and parts of Bolton similarly have above-average T2D. Manchester City’s Longsight, Rusholme, and Levenshulme have substantial Pakistani and Bangladeshi communities with elevated T2D rates. For all of these patients, Mounjaro is uniquely powerful in 2026:
- Dual licence — the only UK weight loss medication licensed for both weight management AND type 2 diabetes control simultaneously
- Exceptional HbA1c reduction — SURPASS-2 (NEJM 2021): 15mg Mounjaro reduced HbA1c by 2.58 percentage points on average — the strongest of any approved T2D treatment
- Simultaneous weight loss — 22.5% average at 15mg alongside glycaemic control (SURMOUNT-1, NEJM 2022)
- QOF T2D pathway (April 2026) — for Oldham and Rochdale patients with 18–24 month tier 3 waits, this pathway could save more than a year of waiting
- Ethnic BMI adjustments — for South Asian T2D patients in Oldham (OL1–OL4, OL8–OL9), the adjusted threshold of BMI 23+ with a qualifying condition means many patients who assumed they didn’t qualify at Slinic are eligible immediately
Private Weight Loss Injections Manchester — Slinic’s Fixed 2026 Prices
MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain and Wegovy from Novo Nordisk’s authorised UK supply chain. Fixed 2026 prices. No subscription. Next-day delivery to all 10 Greater Manchester districts.
| Dose | Slinic price | Delivery | Monthly total | Treatment stage |
|---|---|---|---|---|
| Mounjaro 2.5mg | £139.00 | £4.99 | £143.99 | Starting dose (weeks 1–4). Free starter pack (needles + sharps bin) with first order. |
| Mounjaro 5mg | £165.00 | £4.99 | £169.99 | First therapeutic dose (weeks 5–8). Weight loss accelerating. |
| Mounjaro 7.5mg | £225.00 | £4.99 | £229.99 | Mid-escalation. ~8–9% cumulative average weight loss. |
| Mounjaro 10mg | £255.00 | £4.99 | £259.99 | Upper escalation. 19.5% average weight loss at this dose. |
| Mounjaro 12.5mg | £275.00 | £4.99 | £279.99 | High maintenance. Near-maximum efficacy. |
| Mounjaro 15mg | £285.00 | £4.99 | £289.99 | Maximum dose. 22.5% average weight loss at 72 weeks (SURMOUNT-1 · NEJM 2022). 57% of patients achieved 20%+. |
| Wegovy 0.25mg | £99.99 | £4.99 | £104.98 | Starting dose. Free starter pack included. |
| Wegovy 0.5mg | £109.99 | £4.99 | £114.98 | Month 2. |
| Wegovy 1mg | £114.99 | £4.99 | £119.98 | Month 3. Entering therapeutic range. |
| Wegovy 1.7mg | £159.99 | £4.99 | £164.98 | Month 4. ~10–12% cumulative average. |
| Wegovy 2.4mg | £209.99 | £4.99 | £214.98 | Maintenance. 14.9% average (STEP 1 · NEJM 2021). NICE CV approval April 2026. |
Each pen contains 4 weekly doses. Fixed 2026 prices. No subscription, no minimum term. Compare: MedExpress £179.99 starting · Boots £176.97 starting · Voy £167+ with subscription.
Am I Eligible for Weight Loss Injections in Manchester?
- ✓ BMI 30 or above — no qualifying condition needed at Slinic
- ✓ BMI 27–29.9 with at least one qualifying condition: T2D, hypertension, CVD, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
- ✓ South Asian, Black African/Caribbean, Chinese, Somali, or Middle Eastern background — BMI 27.5+ without condition, or BMI 23+ with condition — applied automatically
- ✓ Age 18 or over
- ✗ Contraindications — personal/family history of MTC or MEN2 · pregnant or breastfeeding · under 18 · active pancreatitis · currently on another GLP-1 agonist
Expected Results — Manchester Patients Starting Mounjaro Now
Based on SURMOUNT-1 (NEJM 2022) — 2,539 patients, 72 weeks. For a Manchester patient starting at 100kg:
| Month | Dose | Average % loss | Actual weight (100kg) | What patients typically experience |
|---|---|---|---|---|
| Month 1 | 2.5mg | ~3–4% | ~3–4 kg | Appetite significantly quieter within 1–2 weeks. Food thoughts reducing. Scale beginning to move. |
| Month 3 | 7.5mg | ~8–9% | ~8–9 kg | Clothes fitting differently. Energy improving. Others beginning to notice. Motivation peaks. |
| Month 6 | 10–12.5mg | ~14–15% | ~14–15 kg | Major transformation. Blood pressure, blood sugar, lipids typically all improved. |
| Month 12 | 15mg | ~20–21% | ~20–21 kg | Profound health transformation. Quality of life, energy, and cardiovascular risk significantly improved. |
| Month 18 | 15mg | 22.5% | ~22.5 kg | Full SURMOUNT-1 result. 57% of 15mg patients achieved 20%+ weight loss. Ready to transition to NHS supply. |
What Slinic Includes for Manchester Patients
| Included | Details |
|---|---|
| Full clinical assessment | Every prescription reviewed by Shadeia Younis or registered clinical team. Contraindication screening, drug interactions, ethnic threshold assessment. Never automated. |
| Free starter pack | Needles and sharps bin with every first order. |
| Free monthly clinical check-ins | Weight progress, dose management, side effect support, nutritional guidance. Always included in price — never charged separately. |
| Next-day cold-chain delivery — all GM postcodes | M1–M90, OL1–OL16, BL1–BL9, WN1–WN8, SK1–SK22, WA14–WA15. Certified 2–8°C. Slinic is in Lancashire — especially fast to GM. |
| No subscription or minimum term | Order when ready. No automatic billing. No cancellation fee. No lock-in. |
| NHS contract + SCOPE + LegitScript | The highest governance standard in UK online weight loss prescribing. Verify GPhC No. 1033729 at pharmacyregulation.org |
Side Effects — What Manchester Patients Need to Know
| Side effect | Rate at 15mg | Timing | What to do |
|---|---|---|---|
| Nausea | ~32% | First 2–4 weeks each dose increase | Smaller meals, avoid high-fat food. Antiemetics at monthly check-in if persistent. |
| Diarrhoea | ~23% | First 2–4 weeks | Reduce high-fibre foods. Increase fluids. Loperamide acutely. |
| Constipation | ~17% | Variable | Increase fibre and fluid. Macrogol sachets from any Manchester pharmacy. |
| Vomiting | ~11% | First 2–4 weeks | Contact Slinic urgently if unable to keep fluids down for 24+ hours. |
| Hair thinning | Common with rapid weight loss | Months 3–6 | Increase protein. Check ferritin with your Manchester GP. Resolves naturally. |
| Injection site reactions | ~7% | Ongoing | Rotate sites. Clean technique. Usually mild and self-resolving. |
Manchester Royal Infirmary — Oxford Road, M13 9WL · Wythenshawe Hospital — Southmoor Road, M23 9LT · North Manchester General Hospital — Delaunays Road, M8 5RB · Royal Oldham Hospital — Rochdale Road, OL1 2JH · Fairfield General Hospital (Bury) — Rochdale Old Road, BL9 7TD · Royal Bolton Hospital — Minerva Road, BL4 0JR · Wrightington, Wigan and Leigh NHS Foundation Trust — Wiend, WN1 1XX · Stepping Hill Hospital (Stockport) — Poplar Grove, SK2 7JE
Severe persistent abdominal pain especially radiating to the back — stop medication immediately, attend nearest A&E. Possible pancreatitis.
Facial swelling or difficulty breathing — call 999 immediately. Possible anaphylaxis.
Unable to keep fluids down for 24+ hours — call Slinic or NHS 111.
Call 111 for urgent non-emergency advice outside GP hours.
Verifying Your Manchester Weight Loss Injection Provider
| Check | Why | Slinic status |
|---|---|---|
| GPhC registration — pharmacyregulation.org | Legal requirement. Only way to verify any UK online pharmacy. MHRA seized 20M counterfeit doses worth £45M in 2025. | ✓ GPhC No. 1033729 |
| NHS contract | Highest UK pharmacy governance standard. | ✓ Yes |
| SCOPE Obesity accreditation | scopeforpractitioners.com | ✓ Yes |
| LegitScript certification | legitscript.com | ✓ Yes |
| Named registered prescriber | Every prescription reviewed by GMC, GPhC, or NMC registered prescriber — not automated. | ✓ Shadeia Younis MPharmS GPhC No. 2052119 |
| Authorised UK supply chain | MHRA-licensed medication from Eli Lilly and Novo Nordisk UK-authorised supply only. | ✓ Eli Lilly + Novo Nordisk UK authorised |
How to Get Started at Slinic — Manchester Patients
- Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation — free, no obligation, no GP referral needed
- Registered prescriber review same working day — Shadeia Younis or her clinical team. Ethnic threshold assessment included. Never automated.
- Medication dispatched within 24 hours — cold-chain to your Greater Manchester postcode. Lancashire-based — particularly fast to GM.
- Free monthly check-in scheduled — all remote, all included in price
- Ask your Manchester or GM GP simultaneously for NHS tier 3 referral, cardiovascular Wegovy pathway, or QOF T2D Mounjaro pathway. Start both routes today.
Frequently Asked Questions — Weight Loss Injections Manchester
Which Greater Manchester districts have the longest NHS waits?
Oldham and Wigan have the longest NHS Greater Manchester ICB tier 3 weight management waiting times, at approximately 18–24 months. Rochdale is 18–22 months. Bolton and Tameside are 15–20 months. Manchester City and Salford are 15–18 months. The shortest waits are in Trafford and Stockport at 12–15 months. The April 2026 QOF T2D Mounjaro pathway is particularly important for Oldham and Rochdale patients — where T2D prevalence is highest and tier 3 waits are longest.
Does Greater Manchester’s devolved health system change my eligibility?
In practical terms for weight loss injection patients — no. NHS Greater Manchester ICB operates under a devolved health and care model since 2016, but eligibility criteria for Mounjaro and Wegovy follow national NICE guidance (TA1026 for tirzepatide, TA875 for semaglutide), the same as the rest of England. The main practical difference is in how tier 3 services are commissioned and delivered across the 10 districts, and local implementation timing for the April 2026 GP direct prescribing pathways.
Does Slinic deliver to Stockport, Wigan, and Rochdale?
Yes — Slinic delivers next-day cold-chain to all 10 Greater Manchester districts: Stockport (SK1–SK12), Wigan (WN1–WN8), Rochdale (OL10–OL16), Oldham (OL1–OL9), Bolton (BL1–BL9), Bury (BL8–BL9), Salford (M3–M7, M27–M30), Trafford (M14–M16, M31–M33, WA14–WA15), Tameside (OL5–OL7, SK14–SK16), and Manchester City (M1–M90). All deliveries certified 2–8°C. Slinic is based in Lancashire — particularly fast delivery to all Greater Manchester postcodes.
Can I get weight loss injections in Oldham privately?
Yes — through Slinic, with next-day delivery to all Oldham OL1–OL4 and OL8–OL9 postcodes. Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation. If you are from a South Asian background (Pakistani, Bangladeshi, Indian) — as a large proportion of Oldham patients are — the ethnic BMI adjustment thresholds of BMI 27.5+ without a condition, or BMI 23+ with a condition (such as T2D or hypertension), apply automatically. Many Oldham patients who assumed they didn’t meet the BMI threshold are in fact immediately eligible at Slinic under adjusted criteria.
Is the QOF T2D Mounjaro pathway available from Manchester GPs?
Yes — from April 2026, NHS Greater Manchester ICB GP practices that have adopted the QOF T2D pathway can potentially prescribe Mounjaro directly for eligible T2D patients, without a tier 3 referral. Adoption varies by practice across the 10 GM districts. Ask your GP specifically: “Has your practice adopted the QOF tirzepatide T2D prescribing pathway?” If your practice hasn’t adopted it yet, private Mounjaro at Slinic from £139/month with next-day delivery to your GM postcode is immediately available — and can run simultaneously with your NHS tier 3 referral.
Can I switch to Slinic from another Manchester provider?
Yes. Cancel or pause your current subscription, complete Slinic’s free assessment, and tell your prescriber your current dose and treatment history. You do not need to restart from the lowest dose if already established on a higher dose. Medication delivered to your Manchester address within 24 hours of prescription approval. Many Manchester patients switch to Slinic for lower fixed prices, free monthly check-ins, and NHS-contract level governance.
External Resources and References
Official NHS and Regulatory Resources
- NICE TA1026 — Tirzepatide for managing overweight and obesity (June 2025)
- NICE TA875 — Semaglutide for managing overweight and obesity (March 2023)
- NICE cardiovascular guidance — Semaglutide for CVD risk reduction (April 2026)
- NHS England — QOF 2026/27 T2D Mounjaro pathway
- GPhC Register — Slinic verification (No. 1033729)
- MHRA — Report counterfeit medicines
- NHS Prepayment Certificate — cap annual costs at £111.60/year
Published Clinical Trial Evidence
- SURMOUNT-1 — Jastreboff AM et al. Tirzepatide Once Weekly for Obesity. NEJM 2022
- STEP 1 — Wilding JPH et al. Semaglutide for Obesity. NEJM 2021
- SURMOUNT-5 — Garvey WT et al. Tirzepatide vs Semaglutide. NEJM 2025
- SELECT — Lincoff AM et al. Semaglutide and Cardiovascular Outcomes. NEJM 2023
- SURPASS-2 — Frias JP et al. Tirzepatide vs Semaglutide in T2D. NEJM 2021
Community Health and Patient Resources
Related Guides
Start Weight Loss Injections in Manchester Today
Same MHRA-licensed medication as NHS Greater Manchester ICB · Fixed 2026 prices · No waiting list · Next-day delivery to all 10 GM districts · GPhC No. 1033729 · Based in Lancashire — fastest delivery to GM
✓ NHS-contracted
✓ SCOPE Obesity Accredited
✓ LegitScript Certified
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ No minimum term
